Becton, Dickinson and Company and Check-Points Receive FDA Clearance for Molecular Screening Test to Detect Antibiotic-Resistant Bacteria
October 29, 2019
October 29, 2019
FRANKLIN LAKES, New Jersey, Oct. 29 -- Becton, Dickinson and Co., a medical technology company, issued the following news release:
FRANKLIN LAKES, N.J., and WAGENINGEN, THE NETHERLANDS, - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms (CPOs) on the fully-auto . . .
FRANKLIN LAKES, N.J., and WAGENINGEN, THE NETHERLANDS, - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms (CPOs) on the fully-auto . . .